Blair William & Co. IL Purchases 343 Shares of Agilent Technologies, Inc. $A

Blair William & Co. IL boosted its position in Agilent Technologies, Inc. (NYSE:A) by 0.9% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 36,535 shares of the medical research company’s stock after buying an additional 343 shares during the period. Blair William & Co. IL’s holdings in Agilent Technologies were worth $4,312,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in A. Generation Investment Management LLP increased its position in Agilent Technologies by 19.8% in the 1st quarter. Generation Investment Management LLP now owns 4,983,556 shares of the medical research company’s stock valued at $582,976,000 after buying an additional 824,243 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Agilent Technologies by 18.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,836,105 shares of the medical research company’s stock valued at $448,748,000 after purchasing an additional 604,124 shares during the last quarter. Mackenzie Financial Corp boosted its stake in Agilent Technologies by 141.5% during the 1st quarter. Mackenzie Financial Corp now owns 935,893 shares of the medical research company’s stock valued at $109,481,000 after purchasing an additional 548,344 shares during the last quarter. Woodline Partners LP boosted its stake in Agilent Technologies by 681.6% during the 1st quarter. Woodline Partners LP now owns 522,073 shares of the medical research company’s stock valued at $61,072,000 after purchasing an additional 455,276 shares during the last quarter. Finally, Parnassus Investments LLC boosted its stake in Agilent Technologies by 38.3% during the 1st quarter. Parnassus Investments LLC now owns 1,577,999 shares of the medical research company’s stock valued at $184,594,000 after purchasing an additional 437,242 shares during the last quarter.

Agilent Technologies Price Performance

Shares of NYSE A opened at $136.62 on Monday. Agilent Technologies, Inc. has a twelve month low of $96.43 and a twelve month high of $153.84. The stock’s 50 day moving average price is $125.04 and its 200-day moving average price is $117.02. The company has a market capitalization of $38.73 billion, a PE ratio of 32.07, a PEG ratio of 4.46 and a beta of 1.26. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.37. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The firm had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter in the previous year, the business earned $1.32 EPS. The company’s revenue was up 10.1% compared to the same quarter last year. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, equities analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th will be paid a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Tuesday, September 30th. Agilent Technologies’s payout ratio is presently 23.24%.

Analyst Upgrades and Downgrades

A has been the subject of a number of analyst reports. UBS Group upgraded Agilent Technologies from a “neutral” rating to a “buy” rating and lifted their price target for the company from $130.00 to $170.00 in a research note on Wednesday, October 8th. Evercore ISI lifted their price target on Agilent Technologies from $128.00 to $140.00 and gave the company an “in-line” rating in a research note on Tuesday, October 7th. JPMorgan Chase & Co. lifted their price target on Agilent Technologies from $155.00 to $165.00 and gave the company an “overweight” rating in a research note on Thursday. Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Friday, October 3rd. Finally, Barclays lifted their price target on Agilent Technologies from $125.00 to $150.00 and gave the company an “equal weight” rating in a research note on Thursday, October 2nd. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $148.69.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.